| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
1 |
| mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |
| mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
1 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |
| mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.0017 |
1 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
1 |
| mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.0017 |
1 |
| mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
1 |